US regulatory nod

Aurobindo in-licenced chemotherapy induced neutropenia drug Ryzneuta gets USFDA nod, sends scrip soaring to 52-week high – Times of India

[ad_1] HYDERABAD: Pharma major Aurobindo Pharma on Wednesday informed the bourses that the US Food & Drug Administration (USFDA) has…